Compare FRAF & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FRAF | CBUS |
|---|---|---|
| Founded | 1906 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.1M | 208.7M |
| IPO Year | 1995 | 2017 |
| Metric | FRAF | CBUS |
|---|---|---|
| Price | $50.33 | $2.15 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 13.2K | ★ 514.2K |
| Earning Date | 04-28-2026 | 03-17-2026 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | ★ 88.84 | 74.33 |
| EPS | ★ 4.74 | N/A |
| Revenue | N/A | ★ $3,639,000.00 |
| Revenue This Year | $14.44 | $126.00 |
| Revenue Next Year | $6.95 | $110.01 |
| P/E Ratio | $10.67 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $32.53 | $1.09 |
| 52 Week High | $57.51 | $4.19 |
| Indicator | FRAF | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 36.38 |
| Support Level | $47.15 | $1.34 |
| Resistance Level | $53.59 | $2.48 |
| Average True Range (ATR) | 1.46 | 0.33 |
| MACD | 0.08 | -0.18 |
| Stochastic Oscillator | 67.49 | 8.52 |
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.